Imaging Brain Networks in Neurodegenerative Diseases
Yong He
DOI: https://doi.org/10.1111/cns.12466
2015-01-01
CNS Neuroscience & Therapeutics
Abstract:Neurodegenerative diseases affect millions of people worldwide and include many different types, such as Alzheimer’s disease (AD), frontotemporal dementia, semantic dementia, amyotrophic lateral sclerosis, and Parkinson’s disease (PD). Patients suffering from these diseases show declines in a variety of cognitive functions, as well as disruptions of brain structures and functions, in parallel with a molecular and pathological progression, such as the accumulation of specific proteins. Despite the differences in the underlying biological mechanisms, important commonalities have been observed among these diseases, leading some researchers to argue that neurodegenerative diseases are brain disorders with misfolded protein aggregates between regions over time as a consequence of diffuse network dynamics [1,2]. Recent advances in multimodal neuroimaging techniques (e.g., structural MRI, functional MRI, diffusion MRI, and positron emission tomography) provide unique opportunities to explore the structural and functional brain abnormalities in patients, in particular from a network perspective, to improve our understanding of the pathophysiological mechanisms of neurodegenerative diseases, and to assist in developing diagnostic biomarkers and assess treatment effects [3,4]. While there are still many challenging issues, such as the extraction of reliable brain connectivity from various imaging modalities and the analyses of the topological properties (e.g., the selection of global and regional metrics), network analysis of neuroimaging data in neurodegenerative diseases has significantly advanced in the past decade, mainly due to the rapid development of imaging analysis methodologies and computational models of brain networks. In this special issue, we aimed to compile works representing recent studies regarding imaging brain networks in neurodegenerative diseases. We collected eleven articles, including five review articles and six original research articles. The article topics covered various research directions in structural and functional brain network studies using neuroimaging data in neurodegenerative diseases such as AD, semantic dementia, and PD. (i) We assembled five review articles. In the first review article, Agosta et al. [5] provided a comprehensive review regarding the recent progress on the most common neurodegenerative diseases (e.g., AD, frontotemporal dementia, amyotrophic lateral sclerosis, and PD) involving the main molecular and pathological substrates of these diseases and neuroimaging findings based on structural and functional brain connectivity analyses. They highlighted the “network-based neurodegeneration” hypothesis in these disorders by representing the large-scale brain network alterations, as well as the microscopic abnormalities of structural pathways. They emphasized that characterizing network breakdown using multimodal MRI data in combination with molecular imaging techniques would be crucial to understanding the biological mechanisms of these neurodegenerative diseases, and they may even help to identify new therapeutic targets to slow or stop the disease progression. Sun et al. [6] and Li et al. [7] provided systematic reviews regarding behavioral, biochemical, and neuroimaging studies in subjective cognitive decline and mild cognitive impairment, respectively. Neurodegeneration due to AD can progress over years before dementia appears. Individuals with mild cognitive impairment have a high risk of progressing to AD, which represents the prodromal stage of this disease. Furthermore, most individuals with mild cognitive impairment are preceded by subjective cognitive decline characterized by self-reported memory complaints. By summarizing the recent progress on structural and functional imaging studies, Sun et al. [6] and Li et al. [7] highlighted that brain network dysfunctions have appeared in both subjective cognitive decline and mild cognitive impairment and emphasized the importance and necessity of considering these early stages in disease diagnosis. Given that both subjective cognitive decline and mild cognitive impairment are heterogeneous and some individuals will not convert to dementia, they also emphasized that longitudinal studies using multimodal neuroimaging techniques are vital for the discovery of diagnostic biomarkers. Yang et al. [8] conducted an exhaustive review of studies that directly or indirectly assessed the structural and functional connectivity alterations of semantic dementia. Their synthesized analyses showed that semantic dementia is associated with extensive changes in terms of both structural and functional networks, encompassing, but not restricted to, regions that are strongly atrophied in semantic dementia, such as the anterior temporal lobe. They highlighted that the relationship between structural and functional connectivity changes, and between these network changes and the core behavioral symptoms of semantic dementia, that is, semantic deficit, is not yet established, marking critical new research directions for the study of this disorder. Finally, Baggio et al. [9] systematically reviewed the recent progress on brain functional network studies using resting-state functional MRI in Parkinson’s disease. Resting-state functional MRI provides a unique opportunity to explore the brain’s spontaneous or intrinsic functional architecture in healthy and disease populations (e.g., AD and PD). By summarizing the findings using resting-state functional MRI, they suggested that there were a number of variabilities in the results across studies. Nonetheless, they emphasized that the resting-state fMRI technique and network analysis approaches are vital for evaluating the pathophysiological mechanisms underlying the clinical and cognitive